J J Valerdi

Summary

Country: Spain

Publications

  1. ncbi Hyperfractionated radiotherapy concomitant with cisplatin and granulocyte colony-stimulating factor (filgrastim) for laryngeal carcinoma
    M Tejedor
    Department of Oncology, Hospital de Navarra, Pamplona, Spain
    Cytokines Cell Mol Ther 6:35-9. 2000

Collaborators

  • F Arias
  • M Tejedor
  • E Pruja
  • M A Dominguez
  • L Mendez
  • J J Illarramendi

Detail Information

Publications1

  1. ncbi Hyperfractionated radiotherapy concomitant with cisplatin and granulocyte colony-stimulating factor (filgrastim) for laryngeal carcinoma
    M Tejedor
    Department of Oncology, Hospital de Navarra, Pamplona, Spain
    Cytokines Cell Mol Ther 6:35-9. 2000
    ..Overall survival was 55% at three years. The administration of filgrastim with this regimen was feasible, and it appeared to reduce the severity and duration of mucositis induced by the combined treatment...